… neurodegenerative diseases, Alzheimer’s disease (AD), and Parkinson’s disease (PD). Most
… disorders, including Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and …

Parkinson's disease (PD) is a neurodegenerative disease that is both common and incurable.
The majority of cases are sporadic and of unknown origin but several genes have been …

Objectives The primary objective is to assess the overall outcome of epilepsy surgery
according to evidence from randomised controlled trials.

… SARS-CoV-2 spike glycoprotein (S)–reactive antibodies … titers of SARS-CoV-2 S–reactive
IgG antibodies targeting both … and SARS-CoV-2 S pseudotypes. Distinguishing preexisting and …

… inferring vaccine efficacy against B.1.617.2 in the UK based on rates of S-gene target failure
during quantitative RT-PCR testing. With increasing case numbers and the proportion of …

… WP Gilks, P Abou-Sleiman, and S Jain did the molecular analysis and collection of results.
Clinical and pathological review of patients with the mutation was by J Lynch and S Gandhi. P …

… (ROCM) has reached epidemic proportion during India’s second wave of COVID-19 pandemic,
… The Chi-square and Fisher’s exact tests were used to compare outcomes. For all tests, p …

Mutations in PINK1 cause autosomal recessive Parkinson's disease. PINK1 is a mitochondrial
kinase of unknown function. We investigated calcium homeostasis and mitochondrial …

Background Patients with acute pulmonary edema often have marked hypertension but,
after reduction of the blood pressure, have a normal left ventricular ejection fraction (≥0.50). …

… (8) have reported a loss of H3-mK9 and Swi6, the HP1 homolog, at centromeric repeats
in S. pombe as a result of mutations in the RNAi system. We examined the effects of …